Compare CVS Health Corp (CVS) vs iShares Core S&P 500 ETF (IVV) Price & Performance

CVS Health CorpTrade

iShares Core S&P 500 ETFTrade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs iShares Core S&P 500 ETF — how do they compare? CVS Health Corp trades at $106.47 (market cap $135.48B), while iShares Core S&P 500 ETF trades at $756.26. The key difference: CVS Health Corp pays a 2.51% dividend while iShares Core S&P 500 ETF pays none. Which is the better fit depends on your goals.

	CVS	IVV
Market Cap	$135.48B	—
Sector	Health	Broad Market / Factor
52-Week High	$106.18	$763.10
52-Week Low	$58.75	$624.65
Enterprise Value	$202.02B	—
Dividend Yield	2.51%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.

The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.

iShares Core S&P 500 ETF

IVV trades at $752.57, down 0.77% with a bullish technical signal from moving averages while oscillators remain neutral. The ETF approaches key resistance near $756-$760 with support at $750-$745. Recent news highlights ongoing AI-driven market dynamics and analyst optimism for S&P 500 targets reaching 8,000+ by year-end, though concerns about valuation and earnings season catalysts persist.

The outlook remains positive with strong institutional sentiment and technical momentum, but stretched valuations and potential market volatility present near-term risks. Earnings season performance will be critical for sustaining the current rally toward record highs.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CVS

Provider trust in payers rises to 6.1 as tech solutions cut admin burdens and improve care navigation.PRNewsWire · 9 hours agoBullish CVS Caremark settles with FTC to enhance drug affordability and transparency for consumers.PRNewsWire · 1 day agoBullish View details →

IVV

Invesco S&P 500 Equal Weight ETF underperforms cheaper cap-weighted funds due to fees, cash drag, and rebalancing costs.24/7 Wall Street · 1 day agoBearish Markets hit highs amid historic overvaluation and record margin debt in H1 2026, signaling caution ahead.ETF Trends · 2 days agoNeutral S&P 500 nears record high with 1.3% weekly gain, up 10.7% YTD in 2026.ETF Trends · 4 days agoNeutral View details →

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

About iShares Core S&P 500 ETF

IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.